HCPCS M0235 at Capital Medical Center
Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, first dose
What Capital Medical Center publishes for this code: as an outpatient
| Who pays | Hospital’s fee (lowest – highest) | Doctor’s fee the hospital lists |
|---|---|---|
| Commercial insurance | $451 – $2,315 | — |
| Medicare Advantage | $500 – $550 | — |
| Cash price | $1,090 | — |
| List price | $2,724 | — |
What Capital Medical Center publishes for this code: during a hospital stay
| Who pays | Hospital’s fee (lowest – highest) | Doctor’s fee the hospital lists |
|---|---|---|
| Commercial insurance | $2,179 – $2,315 | — |
| Cash price | $1,090 | — |
| List price | $2,724 | — |
Bills to expect
The hospital’s fee is the price above. Doctors usually send their own bills. Their amounts here are what original Medicare allows in the rest of Washington for 2026, and a private-plan estimate of 118% to 179% of that (the range found across studies of what insurers pay doctors). Those are estimates, not quotes.
| Bill | What it’s for | Original Medicare allows | Private plan estimate |
|---|---|---|---|
| Hospital's fee | The service | — | The price above |
Compare HCPCS M0235 at every Washington hospital, with Medicare’s reference amounts.